Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Anti-dilutive Securities (Details)

v3.20.2
Net Loss Per Share - Anti-dilutive Securities (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Stock options        
Anti-dilutive securities        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 9,363,265 5,476,547 9,363,265 5,476,547
Warrants on common stock        
Anti-dilutive securities        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 4,024,708 4,024,708 4,024,708 4,024,708
Restricted Stock Units        
Anti-dilutive securities        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 155,833 278,750 155,833 278,750
Underwriters' unit purchase option        
Anti-dilutive securities        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 40,000 40,000 40,000 40,000